Soleno Therapeutics, Inc. (SLNO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1232286,
    "name": "Soleno Therapeutics, Inc.",
    "stock_name": "Soleno Therapeutics, Inc.",
    "full_name": "Soleno Therapeutics, Inc.",
    "name_url": "stocks-analysis/soleno-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "52.68",
    "chg": 4.56,
    "chgp": "9.49%",
    "dir": 1,
    "prev_price": "48.12",
    "mcapval": "3,842.38",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US8342033094",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.22 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/soleno-therapeutics-inc-1232286-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Soleno Therapeutics Forms Death Cross, Signaling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/soleno-therapeutics-forms-death-cross-signaling-potential-bearish-trend-3640344",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SolenoTherapeut_dealthcross_3640344.png",
        "date": "2025-10-20 15:10:23",
        "description": "Soleno Therapeutics, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Despite a strong performance over the past year, the stock is currently facing bearish indicators, with recent volatility contrasting broader market trends."
      },
      {
        "title": "Soleno Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/soleno-therapeutics-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-mixed-signals-3559608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/SolenoTherapeut_technicaldot_3559608.png",
        "date": "2025-09-23 16:15:40",
        "description": "Soleno Therapeutics, Inc. has experienced notable stock fluctuations, with a recent closing price of 56.58. The company has shown strong short-term performance, outpacing the S&P 500, while facing challenges in the longer term. Technical indicators present mixed signals, reflecting the stock's volatility and market dynamics."
      },
      {
        "title": "Is Soleno Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-soleno-therapeutics-inc-technically-bullish-or-bearish-3552236",
        "imagepath": "",
        "date": "2025-09-22 18:06:28",
        "description": "As of 19 September 2025, the technical trend for Soleno Therapeutics, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD remains bullish, indicating mixed signals across time frames. The Bollinger Bands are mildly bearish on the weekly and bearish on the monthly, supporting the bearish stance. Moving averages show a mildly bullish signal on the daily, but this is overshadowed by the overall bearish indicators from the KST, Dow Theory, and OBV, all of which are mildly bearish on both weekly and monthly charts. \n\nIn terms of performance, the stock has returned 21.78% year-to-date, outperforming the S&P 500's 13.31%, but has underperformed over the past month with a return of -18.07% compared to the S&P 500's 3.95%. Overall, the current technical stance is mildly bearish...."
      },
      {
        "title": "Is Soleno Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-soleno-therapeutics-inc-technically-bullish-or-bearish-3545903",
        "imagepath": "",
        "date": "2025-09-20 19:21:08",
        "description": "As of 12 September 2025, the technical trend for Soleno Therapeutics, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD is bullish, indicating mixed signals across time frames. The weekly RSI shows no signal, and Bollinger Bands are mildly bearish on the weekly and sideways on the monthly. Moving averages indicate a mildly bullish stance on the daily chart, but both the KST and Dow Theory are mildly bearish on the weekly and monthly charts. The On-Balance Volume is also mildly bearish on both time frames.\n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -0.25% and -16.90% respectively, while it has outperformed the benchmark year-to-date with a return of 25.87% compared to 12.22%. Overall, the current technical stance is mildly bearish, driven by the bearish indicators on the weekly charts...."
      },
      {
        "title": "Is Soleno Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-soleno-therapeutics-inc-overvalued-or-undervalued-3542568",
        "imagepath": "",
        "date": "2025-09-20 17:56:12",
        "description": "As of 6 August 2025, the valuation grade for Soleno Therapeutics, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued given its negative performance metrics, including a P/E ratio of NA due to losses, a Price to Book Value of 16.38, and a troubling ROE of -82.85%. \n\nIn comparison to its peers, Soleno's EV to EBITDA stands at -17.64, while Arcutis Biotherapeutics, Inc. and EyePoint Pharmaceuticals, Inc. have ratios of -24.8858 and -3.6610, respectively. This suggests that Soleno is not only underperforming relative to its industry but also faces significant challenges in generating positive returns. Notably, over the past year, Soleno's stock has returned 5.66%, significantly lagging behind the S&P 500's return of 17.14%, reinforcing the notion that the stock is overvalued in its current state...."
      },
      {
        "title": "Soleno Therapeutics Experiences Revision in Stock Evaluation Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/soleno-therapeutics-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-stock-decline-3522875",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/SolenoTherapeut_technicaldot_3522875.png",
        "date": "2025-09-16 18:56:27",
        "description": "Soleno Therapeutics, Inc. has experienced significant stock fluctuations, with a recent trading range indicating volatility. While the company has underperformed against the S&P 500 in the short term, it has shown strong year-to-date and three-year growth, highlighting its dynamic position in the pharmaceuticals and biotechnology sector."
      }
    ],
    "total": 10,
    "sid": "1232286",
    "stock_news_url": "https://www.marketsmojo.com/news/soleno-therapeutics-inc-1232286"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Soleno Therapeutics Forms Death Cross, Signaling Potential Bearish Trend

2025-10-20 15:10:23

Soleno Therapeutics, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Despite a strong performance over the past year, the stock is currently facing bearish indicators, with recent volatility contrasting broader market trends.

Soleno Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations

2025-09-23 16:15:40

Soleno Therapeutics, Inc. has experienced notable stock fluctuations, with a recent closing price of 56.58. The company has shown strong short-term performance, outpacing the S&P 500, while facing challenges in the longer term. Technical indicators present mixed signals, reflecting the stock's volatility and market dynamics.

Is Soleno Therapeutics, Inc. technically bullish or bearish?

2025-09-22 18:06:28

As of 19 September 2025, the technical trend for Soleno Therapeutics, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD remains bullish, indicating mixed signals across time frames. The Bollinger Bands are mildly bearish on the weekly and bearish on the monthly, supporting the bearish stance. Moving averages show a mildly bullish signal on the daily, but this is overshadowed by the overall bearish indicators from the KST, Dow Theory, and OBV, all of which are mildly bearish on both weekly and monthly charts. In terms of performance, the stock has returned 21.78% year-to-date, outperforming the S&P 500's 13.31%, but has underperformed over the past month with a return of -18.07% compared to the S&P 500's 3.95%. Overall, the current technical stance is mildly bearish....

Is Soleno Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:21:08

As of 12 September 2025, the technical trend for Soleno Therapeutics, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD is bullish, indicating mixed signals across time frames. The weekly RSI shows no signal, and Bollinger Bands are mildly bearish on the weekly and sideways on the monthly. Moving averages indicate a mildly bullish stance on the daily chart, but both the KST and Dow Theory are mildly bearish on the weekly and monthly charts. The On-Balance Volume is also mildly bearish on both time frames. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -0.25% and -16.90% respectively, while it has outperformed the benchmark year-to-date with a return of 25.87% compared to 12.22%. Overall, the current technical stance is mildly bearish, driven by the bearish indicators on the weekly charts....

Is Soleno Therapeutics, Inc. overvalued or undervalued?

2025-09-20 17:56:12

As of 6 August 2025, the valuation grade for Soleno Therapeutics, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued given its negative performance metrics, including a P/E ratio of NA due to losses, a Price to Book Value of 16.38, and a troubling ROE of -82.85%. In comparison to its peers, Soleno's EV to EBITDA stands at -17.64, while Arcutis Biotherapeutics, Inc. and EyePoint Pharmaceuticals, Inc. have ratios of -24.8858 and -3.6610, respectively. This suggests that Soleno is not only underperforming relative to its industry but also faces significant challenges in generating positive returns. Notably, over the past year, Soleno's stock has returned 5.66%, significantly lagging behind the S&P 500's return of 17.14%, reinforcing the notion that the stock is overvalued in its current state....

Soleno Therapeutics Experiences Revision in Stock Evaluation Amid Market Volatility

2025-09-16 18:56:27

Soleno Therapeutics, Inc. has experienced significant stock fluctuations, with a recent trading range indicating volatility. While the company has underperformed against the S&P 500 in the short term, it has shown strong year-to-date and three-year growth, highlighting its dynamic position in the pharmaceuticals and biotechnology sector.

View All News